Skip to Content

Supportive Care Service (WF 1803CD)

Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices



The purpose of this study is to understand current practices for engaging with informal (unpaid) caregivers of patients with cancer, characterize the availability of supportive care services, and assess the perspectives of multi-disciplinary oncology health care providers regarding identifying and supporting caregivers.

Key Inclusion Criteria

Inclusion Criteria:

  • NCI Community Oncology Research Program (NCORP) components/subcomponents providing care to adult oncology patients.
  • NCORP components/subcomponents willing to: a) identify a supportive care leader knowledgeable about supportive care services that may be available to the practice and b) assist with the identification and recruitment of oncology providers for a brief provider survey.
  • NCORP components/subcomponents who share staff and supportive care services may participate as a single practice group
  • A staff member at each site who is most knowledgeable about supportive care services for adult oncology patients (e.g., Director of Manger of Psychosocial Oncology, Supportive Care Services, or Cancer Patient Support). If an administrator or leader cannot be identified, the nurse manager or clinic director will be asked to identify a staff member most knowledgeable about psychosocial or supportive care services for adult oncology patients or complete the survey himself or herself.
  • Must be a physician, nurse, or physician assistant/nurse practitioner, who routinely provides cancer care to adult oncology patients, including medical, radiation and surgical oncologists or physician assistants (PAs), nurse practitioners (NPs), and nurses who work in oncology settings.
  • Must have been in practice at component/subcomponent for at least 6 months.

Key Exclusion Criteria

  • Exclusion Criteria:

    • Component/subcomponent exclusively care for pediatric oncology patients. Given the distinct caregiver experience and needs of caregivers of pediatric oncology patients, we are not including components/sub-components that exclusively provide care for pediatric oncology patients.
    • Providers in practice less than 6 months.

Study Type: Observational

Learn More


IRB Protocol Number
WF 1803CD
Principal Investigator(s)
James D. Bearden III, M.D.

Clinical Trial Categories

  • Cancer Care Delivery Research (CCDR)
  • Oncology
Wake Forest University Health Sciences
Melyssa Foust, RN at 864-560-1035
How to Participate

Melyssa Foust, RN


Was this page helpful?


Thank you for your feedback!

Thank you for your feedback and helping us to improve our website.
There will be no additional response.

News & Highlights

Stay Connected!

Get the latest news on the health topics that matter most to you.

Sign up